(IS3N) iShares Core MSCI Emerging - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BKM4GZ66

IS3N: Emerging, Markets, Equities, ETF

The iShares Core MSCI Emerging Markets IMI UCITS ETF (Ticker: IS3N), listed on XETRA, provides exposure to a broad range of emerging market equities. It tracks the Morningstar Emerging Markets Target Market Exposure Net Return USD Index, offering a diversified portfolio of companies across various emerging economies. The ETF is structured as a UCITS-compliant fund, adhering to European regulatory standards, and is managed by BlackRock, a leading global asset manager. With an average daily trading volume of 275,773 shares over the past 20 days, the fund exhibits moderate liquidity. Its current price of 29.85 EUR reflects recent market movements, while its short-term (20-day) and long-term (200-day) moving averages of 31.00 and 32.45, respectively, indicate a recent downtrend. The funds annualized volatility, as measured by the ATR of 0.64, suggests relatively stable price fluctuations.

From a fundamental perspective, the ETF holds assets under management (AUM) of 24,553.77 million EUR, underscoring its popularity among investors seeking emerging market exposure. The funds broad diversification across emerging economies reduces concentration risk, though it remains exposed to macroeconomic and geopolitical risks inherent to these markets. Its expense ratio, while not explicitly mentioned, is typically competitive for a core emerging markets ETF. The funds structure allows for efficient tracking of its underlying index, making it a cost-effective choice for long-term investors.

3-Month Forecast: Based on the provided and , the ETF is likely to face headwinds in the near term. The 20-day SMA (31.00) is below the 50-day (32.40) and 200-day (32.45) SMAs, signaling a bearish trend. However, the moderate average daily volume of 275,773 shares suggests sufficient liquidity to support trading activity. The ATR of 0.64 indicates controlled volatility, which may limit sharp price swings. The substantial AUM of 24,553.77M EUR reflects investor confidence and suggests stability in the funds operations. Overall, the ETF is expected to remain under pressure in the next three months, with potential downside limited by its diversified portfolio and stable volatility metrics.

Additional Sources for IS3N ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

IS3N ETF Overview

Market Cap in USD 27,586m
Category Global Emerging Markets Equity
IPO / Inception 2014-05-30

IS3N ETF Ratings

Growth Rating 31.7
Fundamental -
Dividend Rating 0.0
Rel. Strength -18.9
Analysts -
Fair Price Momentum 29.24 EUR
Fair Price DCF -

IS3N Dividends

Currently no dividends paid

IS3N Growth Ratios

Growth Correlation 3m 1.6%
Growth Correlation 12m 28.7%
Growth Correlation 5y 36.2%
CAGR 5y 6.43%
CAGR/Max DD 5y 0.27
Sharpe Ratio 12m 1.06
Alpha -3.24
Beta 0.606
Volatility 13.45%
Current Volume 756.9k
Average Volume 20d 243.8k
What is the price of IS3N shares?
As of June 01, 2025, the stock is trading at EUR 32.39 with a total of 756,935 shares traded.
Over the past week, the price has changed by -1.12%, over one month by +4.96%, over three months by -4.67% and over the past year by +4.71%.
Is iShares Core MSCI Emerging a good stock to buy?
Neither. Based on ValueRay´s Analyses, iShares Core MSCI Emerging is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 31.71 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IS3N is around 29.24 EUR . This means that IS3N is currently overvalued and has a potential downside of -9.73%.
Is IS3N a buy, sell or hold?
iShares Core MSCI Emerging has no consensus analysts rating.
What are the forecasts for IS3N share price target?
According to our own proprietary Forecast Model, IS3N iShares Core MSCI Emerging will be worth about 33.1 in June 2026. The stock is currently trading at 32.39. This means that the stock has a potential upside of +2.16%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 33.1 2.2%